# Prednisone vs Colchicine for Gout Flares: When to Use Each One
When NSAIDs aren’t an option for treating your gout flare, two alternatives stand out: colchicine and corticosteroids like prednisone. Both are ACR-recommended treatments, but they work differently and suit different patient populations.
Understanding when each medication is appropriate can help you have a more informed discussion with your healthcare provider.
## How Prednisone and Colchicine Work
### Colchicine
Colchicine is an ancient medication derived from the autumn crocus plant. It works by binding to tubulin, a protein essential for cell division and neutrophil function. By inhibiting neutrophil migration and activity, colchicine interrupts the inflammatory cascade triggered by monosodium urate crystals.
**Key mechanism:** Colchicine prevents neutrophil-mediated inflammation without suppressing overall immune function.
### Prednisone
Prednisone is a synthetic corticosteroid that mimics cortisol, your body’s natural anti-inflammatory hormone. It works by:
– Inhibiting phospholipase A2, reducing prostaglandin and leukotriene production
– Suppressing multiple inflammatory pathways
– Reducing capillary permeability
– Causing neutrophil demargination
**Key mechanism:** Broad suppression of inflammatory and immune responses.
## Comparing Key Features
| Aspect | Colchicine | Prednisone |
|——–|————|————|
| **Mechanism** | Anti-neutrophil | Broad immunosuppression |
| **Onset** | 12-24 hours for full effect | 4-24 hours |
| **Dosing regimen** | Loading dose followed by tapering | Tapered course |
| **Duration of therapy** | 3-7 days typically | 5-14 days |
| **Cost** | Moderate (generic available) | Low (generic) |
| **Availability** | Prescription only | Prescription only |
## When to Choose Colchicine
### Best situations for colchicine:
**1. Patients with cardiovascular disease**
Colchicine has no significant cardiovascular effects, making it safe for patients who have had heart attacks or strokes. This is a major advantage over NSAIDs.
**2. Patients with kidney disease**
While dose adjustment is needed, colchicine can be used in patients with varying degrees of kidney impairment. Prednisone is generally safer for severe kidney disease.
**3. Early intervention**
Colchicine is most effective when started within 12-24 hours of flare onset. If you catch your flare early, colchicine may resolve it faster.
**4. Post-operative gout**
After joint surgery, colchicine is often preferred because it doesn’t interfere with wound healing like corticosteroids can.
**5. Patients on drug interactions**
Colchicine has fewer problematic interactions than prednisone in some cases, though it does interact with certain antibiotics and heart medications.
### When colchicine may not be ideal:
– Late-stage flares (>48 hours) — less effective
– Severe, established inflammation — may need stronger intervention
– Patients taking contraindicated medications (certain CYP3A4 inhibitors)
## When to Choose Prednisone
### Best situations for prednisone:
**1. Contraindications to NSAIDs and colchicine**
Prednisone is often the fallback option when other treatments aren’t suitable.
**2. Multiple joint involvement (polyarticular gout)**
Prednisone’s systemic anti-inflammatory effect makes it better suited for flares affecting multiple joints.
**3. Severe inflammation requiring rapid control**
Prednisone often provides faster, more potent relief for severe flares.
**4. Patients with gout tophi**
The potent anti-inflammatory effect helps manage inflammation around tophaceous deposits.
**5. Refractory cases**
When colchicine or NSAIDs haven’t provided adequate relief, prednisone is an effective option.
### When prednisone may not be ideal:
– Patients with uncontrolled diabetes (raises blood sugar)
– Patients with active infections
– Patients with osteoporosis or avascular necrosis
– Patients on certain medications that interact with corticosteroids
## Side Effect Comparison
### Colchicine side effects:
– **Common:** Diarrhea, nausea, abdominal cramping (often resolves with dose reduction)
– **Less common:** Hair loss, peripheral neuropathy, bone marrow suppression (rare)
– **Serious (rare):** Myotoxicity, especially in patients with kidney impairment or on interacting drugs
### Prednisone side effects:
– **Short-term (acute use):** Increased appetite, mood changes, insomnia, elevated blood sugar, fluid retention
– **Long-term (prolonged use):** Weight gain, osteoporosis, adrenal suppression, increased infection risk, cataracts
For short-term flare treatment (7-14 days), prednisone’s side effects are generally manageable and reversible.
## Dosing Protocols
### Colchicine (FDA-approved regimen):
**Option 1 — High-dose “European” protocol:**
– 1.2 mg initially, then 0.6 mg one hour later
– Repeat cycle every 12 hours as needed (max 1.8 mg first hour, then 1.2 mg/hour)
– Taper based on symptom resolution
**Option 2 — Low-dose protocol (ACR preferred):**
– 1.2 mg initially, then 0.6 mg one hour later
– 0.6 mg once or twice daily until flare resolves
– Lower doses = fewer GI side effects
**Dose reduction for kidney impairment:**
– eGFR 30-50: Reduce dose by 50%
– eGFR <30: Use with caution, maximum 0.6 mg/day
Prednisone protocol:
**Typical acute gout flare dose:**
– Day 1-3: 30-40 mg daily (or divided doses)
– Day 4-7: Taper to 20-25 mg daily
– Day 8-10: Taper to 10-15 mg daily
– Day 11-14: Taper to 5-10 mg daily, then stop
**Alternative:** A 5-7 day course of 30-40 mg daily without taper may be adequate for mild flares, per some clinical guidelines.
Special Population Considerations
Diabetes
Prednisone significantly raises blood glucose levels. Diabetic patients should:
– Monitor blood sugar more frequently during prednisone use
– Consider colchicine as an alternative
– Discuss temporary diabetes medication adjustments with their doctor
Hypertension
Both medications can affect blood pressure:
– Colchicine: Generally neutral or slightly lowering
– Prednisone: Can cause fluid retention and blood pressure elevation
Heart Failure
– Colchicine: Generally safe
– Prednisone: May worsen fluid retention; use cautiously
Osteoporosis
Short-term prednisone use (1-2 weeks) has minimal bone effects. However, patients with existing osteoporosis should be cautious with repeated prednisone courses.
Can They Be Used Together?
The ACR notes that combination therapy may be appropriate for severe flares unresponsive to monotherapy. Combining low-dose colchicine with low-dose prednisone or NSAIDs can provide synergistic relief.
However, this approach increases side effect risks and should only be used under close medical supervision.
Making Your Decision
Your choice between colchicine and prednisone depends on:
| Factor | Favors Colchicine | Favors Prednisone |
|——–|——————-|——————-|
| **Kidney function** | Mild-moderate impairment | Severe impairment |
| **Cardiovascular disease** | Yes | Requires caution |
| **Diabetes** | Preferred choice | Raises blood sugar |
| **Multiple joints affected** | Less ideal | Better choice |
| **Early flare (<24h)** | Yes | Yes |
| **Late flare (>48h)** | Less effective | Better choice |
| **Polyarticular disease** | Limited use | Preferred choice |
## Bottom Line
Both colchicine and prednisone are effective treatments for acute gout flares when NSAIDs aren’t suitable.
**Colchicine** is preferred when you need:
– Cardiovascular safety
– Early intervention
– Polyarticular flares aren’t present
– Treatment of patients with certain infections or other specific conditions
**Prednisone** is preferred when you need:
– Rapid control of severe inflammation
– Treatment of polyarticular disease
– Patients with contraindications to colchicine and NSAIDs
Work with your rheumatologist to develop a personalized flare management plan that considers your complete medical history.
—
For more information on colchicine specifically, see our detailed colchicine dosage and side effects guide. To understand how prednisone fits into the broader landscape of urate-lowering medications, compare it with options like allopurinol vs febuxostat.
References
- American College of Rheumatology. 2020 Guideline for the Management of Gout. Arthritis Care & Research. 2020. PubMed
- Food and Drug Administration. Colchicine Product Labeling. FDA.gov
- Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis. 2017;76(1):29-42. PubMed
- van der Heijde D, et al. Update on gout therapy. J Clin Rheumatol. 2008. PubMed
- FDA Drug Safety Communication. New Safety Requirements for Colchicine. 2010. FDA.gov